Limits...
Prostate brachytherapy in New South Wales: patterns of care study and impact of caseload on treatment quality.

Thompson SR, Delaney GP, Gabriel GS, Izard MA, Hruby G, Jagavkar R, Bucci J, Barton MB - J Contemp Brachytherapy (2014)

Bottom Line: We performed the first comprehensive, population-based brachytherapy (BT) Patterns of Care Study in the Australian setting.Quality was compared between higher and lower caseload departments.Rates of concordance with quality benchmarks were high (85-99%) with no consistent caseload effect identified.

View Article: PubMed Central - PubMed

Affiliation: Collaboration for Cancer Outcomes Research and Evaluation (CCORE), Liverpool Hospital, Sydney ; Department of Radiation Oncology, Prince of Wales Hospital, Sydney ; University of New South Wales, Faculty of Medicine, Sydney.

ABSTRACT

Purpose: We performed the first comprehensive, population-based brachytherapy (BT) Patterns of Care Study in the Australian setting. Herein we report on prostate BT and assess the technical quality of BT practice, focusing on whether a caseload effect could be identified in New South Wales (NSW).

Material and methods: Site visits were made to all radiation oncology departments in NSW that delivered prostate BT, collecting relevant data on NSW residents treated with prostate BT in 2003. Overall quality of NSW prostate BT treatment was assessed using benchmarks including treatment of appropriate prostate cancer disease risk category, absence of (relative) physical contraindications, optimal planned and treated dosimetry, and pre-/post-implant planning/CT. Quality was compared between higher and lower caseload departments.

Results: One hundred and fifty-seven (67%) patients underwent temporary BT and 79 (33%) permanent seed BT. Prostate BT was concentrated in five departments, with three of four departments with active programmes treating greater than the recommended 25 cases. Rates of concordance with quality benchmarks were high (85-99%) with no consistent caseload effect identified.

Conclusions: Prostate BT in NSW in 2003 was generally of high quality and a caseload effect on quality could not be identified. This may be because the number of departments was insufficient to determine a caseload effect, or because the prostate BT was largely concentrated in a small number of high caseload departments.

No MeSH data available.


Related in: MedlinePlus

Temporary brachytherapy. Dose parameters. Horizontal line – median value, vertical box – 25th-75th percentiles, vertical line – range. The y-axis represents Gray for D90 (Gy), % of prescribed dose for D90 (% prescribed) and % of prostate volume for V200/150/100
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4300355&req=5

Figure 0002: Temporary brachytherapy. Dose parameters. Horizontal line – median value, vertical box – 25th-75th percentiles, vertical line – range. The y-axis represents Gray for D90 (Gy), % of prescribed dose for D90 (% prescribed) and % of prostate volume for V200/150/100

Mentions: Treatment protocols varied between departments and are detailed in Table 3, and the boxplot in Figure 2 shows dose parameters prescribed.


Prostate brachytherapy in New South Wales: patterns of care study and impact of caseload on treatment quality.

Thompson SR, Delaney GP, Gabriel GS, Izard MA, Hruby G, Jagavkar R, Bucci J, Barton MB - J Contemp Brachytherapy (2014)

Temporary brachytherapy. Dose parameters. Horizontal line – median value, vertical box – 25th-75th percentiles, vertical line – range. The y-axis represents Gray for D90 (Gy), % of prescribed dose for D90 (% prescribed) and % of prostate volume for V200/150/100
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4300355&req=5

Figure 0002: Temporary brachytherapy. Dose parameters. Horizontal line – median value, vertical box – 25th-75th percentiles, vertical line – range. The y-axis represents Gray for D90 (Gy), % of prescribed dose for D90 (% prescribed) and % of prostate volume for V200/150/100
Mentions: Treatment protocols varied between departments and are detailed in Table 3, and the boxplot in Figure 2 shows dose parameters prescribed.

Bottom Line: We performed the first comprehensive, population-based brachytherapy (BT) Patterns of Care Study in the Australian setting.Quality was compared between higher and lower caseload departments.Rates of concordance with quality benchmarks were high (85-99%) with no consistent caseload effect identified.

View Article: PubMed Central - PubMed

Affiliation: Collaboration for Cancer Outcomes Research and Evaluation (CCORE), Liverpool Hospital, Sydney ; Department of Radiation Oncology, Prince of Wales Hospital, Sydney ; University of New South Wales, Faculty of Medicine, Sydney.

ABSTRACT

Purpose: We performed the first comprehensive, population-based brachytherapy (BT) Patterns of Care Study in the Australian setting. Herein we report on prostate BT and assess the technical quality of BT practice, focusing on whether a caseload effect could be identified in New South Wales (NSW).

Material and methods: Site visits were made to all radiation oncology departments in NSW that delivered prostate BT, collecting relevant data on NSW residents treated with prostate BT in 2003. Overall quality of NSW prostate BT treatment was assessed using benchmarks including treatment of appropriate prostate cancer disease risk category, absence of (relative) physical contraindications, optimal planned and treated dosimetry, and pre-/post-implant planning/CT. Quality was compared between higher and lower caseload departments.

Results: One hundred and fifty-seven (67%) patients underwent temporary BT and 79 (33%) permanent seed BT. Prostate BT was concentrated in five departments, with three of four departments with active programmes treating greater than the recommended 25 cases. Rates of concordance with quality benchmarks were high (85-99%) with no consistent caseload effect identified.

Conclusions: Prostate BT in NSW in 2003 was generally of high quality and a caseload effect on quality could not be identified. This may be because the number of departments was insufficient to determine a caseload effect, or because the prostate BT was largely concentrated in a small number of high caseload departments.

No MeSH data available.


Related in: MedlinePlus